Topic Highlight
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Feb 14, 2008; 14(6): 864-875
Published online Feb 14, 2008. doi: 10.3748/wjg.14.864
Table 1 Representative studies investigating in vitro and/or in vivo hepatocyte differentiation of MSCs
Cell sourceIn vitrodifferentiationIn vivodifferentiationReferences
Human BM&UCB immunoselectionCocktail: EGF-bFGF (2 d), HGF-bFGF-nicot (7 d), OSM-dexa-ITS Characterization: RT-PCR (8), ICC (2), urea production, LDL uptake, PRODNDLee et al[8]
Human UCBNDHost: preimmune fetal sheep Injury: - Cell characterization: Alb+, HepPar1+ Fusion: microdissection + PCR: - Repopulation rate: > 20%Kögler et al[16]
Human adipose tissueCocktail: DMSO-HGF-OSM Characterization: RT-PCR (4), ICC (1), urea production, LDL uptakeHost: NOD/SCID mice Injury: CCl4 TRP: 1.106 cells, tail vein Cell characterization: Alb+/CM-Dil+ Repopulation rate: up to 0.13% Alb+ at 10 dSeo et al[22]
Human BM MSCs, CD34+ cells, non MSCs/CD34- cellsNDHost: WT rats (+CsA) Injury: AA TRP: 1.106 cells, liver Cell characterization: Alb+, CK18+, CK19+, αFP+, AGPR+, serum Alb+ Fusion: FISH hum Y/rat chr 12: -Sato et al[21]
Human BMCocktail: 5'aza (1 d) - EGF-EGF (14 d) Characterization: RT-PCR (11), ICC (4), WB (4), urea production, PAS, reporter gene construct for PEPCK activityHost: Pfp/Rag2-/- mice Injury: propanolol, partial hepatect TRP: 1.106 cells, liver Cell characterization: Alb+, HepPar-1+, PEPCK+, CX32+, PAS+ Fusion: FISH hum alu/mouse satellite: -Aurich et al[10]
Human BMCocktail: HGF-FGF4-ITS-nicot (7 d), OSM-dexa-ITS (15 d) Characterization: RT-PCR (17), ICC (8), flow cytometry, urea&Alb production, PAS, G6Pase activity, neoglucogenesisHost: SCID mice Injury: partial hepatect or retrorsine/AA TRP: 1.106 cells, spleen or liver Cell characterization: Alb+, αFP+, CK18+, fibronectin+, vimentin+, hum alu+Lysy et al[106]
Table 2 Representative studies investigating in vitro and/or in vivo hepatocyte differentiation of HSCs
Cell sourceIn vitrodifferentiationIn vivodifferentiationReferences
Mouse BMNDHost: irradiated FAH-/- mice Injury: NTBC withdrawal TRP: 10 to 1000 cells; retroorbital plexus Cell characterization: β-gal+, Alb+, DPPIV+, e-cadherin+, FISH Y+, liver function, FAH activity Repopulation rate: 30%-50% βgal+ cellsLagasse et al[73]
Mouse BMNDHost: irradiated CD45.1+ mice Injury: hepatect or anti-Fas Ab treatment TRP: 106 cells; vein Cell characterization: CK8+, CK18+, CK19+, CD45.2+, FISH Y+, PCR Bcl-2+ Repopulation rate: up to 0.05%-0.8% with anti-Fas Ab treatmentMallet et al[74]
Human UCB&BMNDHost: irradiated NOD/SCID mice ± HGF Injury: CCl4 TRP: 2000 to 105 cells; vein Cell characterization: Alb+, CD45-, human alu+, CK19+, Alb mRNA+, serum Alb+ Repopulation rate: < 1%Wang et al[77]
Human UCB&PBNDHost: irradiated NOD/SCID mice Injury: CCl4 TRP: 2 to 6 × 105 CD34+ cells; tail vein Cell characterization: CD45+, Alb+, α1-AT+, hum DNA+, hum Alb mRNA+&prot+ Repopulation rate: ≤ 0.01% hum Alb mRNA in mice vs human liverKollet et al[70]
Mouse BMCocktail: co-culture with damaged liver tissue Characterization: RT-PCR (8), ICC (10), FISH Alb mRNAHost: mice ± irradiation Injury: CCl4 TRP: 105 cells; tail vein Cell characterization: Alb+, FISH Y+, E-cadh+, PKH26+, serum liver function Repopulation rate: up to 7.6% at 2 d Fusion: FISH X-Y: -Jang et al[69]
Mouse BMNDHost: mice ± irradiation ± rhG-CSF Injury: partial hepatect or CCl4 TRP: 5 × 103 selected cells or 5 × 105 MNCs; spleen Cell characterization: no co-eGFP/DPPIV staining, PCR eGFP- Repopulation rate: 0/6.9 × 107 host hepatocytesCantz et al[65]